Article
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.
Cellular and molecular life sciences : CMLS - 11 Jul 2022
Carrizzo Albino, Iside Concetta, Nebbioso Angela, Carafa Vincenzo, Damato Antonio, Sciarretta Sebastiano, Frati Giacomo, Di Nonno Flavio, Valenti Valentina, Ciccarelli Michele, Venturini Eleonora, Scioli Mariarosaria, Di Pietro Paola, Bucci Tommaso, Giudice Valentina, Storto Marianna, Serio Bianca, Puca Annibale Alessandro, Giugliano Giuseppe, Trimarco Valentina, Izzo Raffaele, Trimarco Bruno, Selleri Carmine, Altucci Lucia, Vecchione Carmine
Abstract excerpt
Beyond well-assessed risk factors, cardiovascular events could be also associated with the presence of epigenetic and genetic alterations, such as the methylenetetrahydrofolate-reductase (MTHFR) C677T polymorphism. This gene variant is related to increased circulating levels of homocysteine (Hcy) and cardiovascular risk. However, heterozygous carriers have an augmented risk of cardiovascular accidents...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
